Browse All

Current Filters

CLEAR FILTER x

TITLE

Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom

Author:van Eeghen, Agnies   Wilson, Sarah   Smith, Douglas   Strowd, Roy   Boggs, Jane   Greco, Teresa   Stevens, Joanne   Moore-Ramdin, Lisa   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.005  

Author Institution:Emma Children’s Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands  McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX  Minnesota Epilepsy Group, Roseville, MN  Wake Forest School Of Medicine, Winston Salem, NC  Wake Forest School of Medicine, Winston-Salem, NC  Jazz Pharmaceuticals, Inc. , Villa Guardia, Italy  Jazz Pharmaceuticals, Inc., Philadelphia, PA  Jazz Pharmaceuticals, Inc. , London, United Kingdom  

Structural Differences in Rapid-onset Dystonia Parkinsonism (RDP): A Comparative MRI Study

Author:Alcus, Claire   Napoli, Eleonora   Simonyan, Kristina   Ozelius, Laurie   Snively, Beverly   Sweadner, Kathleen   Brashear, Allison   Haq, Ihtsham   

Session Name:P10: Movement Disorders: Hyperkinetic Movement Disorders: Dystonia, Chorea, Tics, Myoclonus, and RLS  

Topic:Movement Disorders  

Program Number:P10.022  

Author Institution:University of Miami Miller School of Medicine, Miami, FL  University of California Davis, Sacramento, CA  Massachusetts Eye and Ear and Harvard Medical School, Boston, MA  Massachusetts General Hospital and Harvard Medical School, Boston, MA  Wake Forest School of Medicine, Winston-Salem, NC  Massachusetts General Hospital, Boston, MA  University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY